- Research article
- Open Access
- Open Peer Review
The association between interpregnancy interval and birth weight: what is the role of maternal polyunsaturated fatty acid status?
© Smits et al; licensee BioMed Central Ltd. 2013
- Received: 4 November 2011
- Accepted: 10 January 2013
- Published: 25 January 2013
The objective of this study was to evaluate the mediating role of maternal early pregnancy plasma levels of long chain polyunsaturated fatty acids (LCPUFAs) in the association of interpregnancy interval (IPI) with birth weight and smallness for gestational age (SGA) at birth.
We analysed a subsample of the Amsterdam Born Children and their Development (ABCD) cohort, comprising 1,659 parous pregnant women recruited between January 2003 and March 2004. We used linear and logistic regression to evaluate the associations between fatty acid status, interpregnancy interval and pregnancy outcome.
Low plasma phospholipids concentrations of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and dihomo-gamma-linolenic acid (DGLA), and high concentrations of arachidonic acid (AA) during early pregnancy were associated with reduced birth weight and/or an increased risk of SGA. Short IPIs (< 6 months, with 18–23 months as a reference) were associated with a mean decrease of 207.6 g (SE: ± 73.1) in birth weight (p = 0.005) and a twofold increased risk of SGA (OR: 2.05; CI: 0.93–4.51; p = 0.074). Adjustment for maternal fatty acid concentrations did not affect these results to any meaningful extent.
Despite the observed association of maternal early pregnancy LCPUFA status with birth weight and SGA, our study provides no evidence for the existence of an important role of maternal EPA, DHA, DGLA or AA in the association of short interpregnancy intervals with birth weight and SGA.
- Birth Weight
- Adverse Pregnancy Outcome
- Fatty Acid Status
- Interpregnancy Interval
- Arachidonic Acid Concentration
Interpregnancy intervals (IPIs) shorter than six months are linked with increased risks of preterm birth, lower birth weight and smallness for gestational age (SGA) [1–3]. These adverse pregnancy outcomes are associated with perinatal and neonatal morbidity and mortality and can affect later development and health . Long-term effects have also been described, including increased risks of schizophrenia, menstrual disorders and subfecundity [5–7].
The mechanisms underlying the unfavourable effects of short IPIs on pregnancy outcomes are not well understood. Some causal hypotheses have been put forward, including postpartum hormonal imbalance, maternal stress and the maternal nutritional depletion hypothesis [8–10]. The latter hypothesis states that women with closely spaced births have insufficient time to restore the nutritional reserves needed to support fetal growth in the subsequent pregnancy, resulting in an increased risk of unfavourable pregnancy outcome. Nutrients of interest in the nutritional depletion hypothesis have to meet several criteria: (1) they have to be necessary in pregnancy and fetal development, with shortage leading to an adverse pregnancy outcome; (2) their maternal functional status should decline during pregnancy; and (3) their normalisation to a sufficient concentration after pregnancy has to be slow. The micronutrients folate and iron fit this profile [11, 12]. Indeed, in a recent study, the association between short interpregnancy interval and pregnancy outcome was found to be stronger among women with low periconceptional folic acid supplement intake .
Nutrients that could play a similar role in the relationship between short interpregnancy interval and adverse pregnancy outcome are the longer-chain, more unsaturated derivatives of the essential fatty acids α-linolenic acid and linoleic acid, also known as long chain polyunsaturated fatty acids (LCPUFAs). This particularly holds for docosahexaenoic acid (DHA, 22:6n-3), eicosapentaenoic acid (EPA, 20:5n-3), arachidonic acid (AA, 20:4n-6) and its precursor, dihomo-gamma-linolenic acid (DGLA, 20:3n-6), which are structural components of cell membranes and are involved in a range of physiologic processes relevant to fetal growth, development and immune system [14–17]. Consequently, a shortage of any of these essential fatty acids could result in a less favourable pregnancy outcome.
A decrease in biochemical LCPUFA status is common in pregnant women [18, 19]. This is probably explained by fetal needs during development, since the developing fetus completely depends on the maternal essential fatty acids supply . Complete recovery after delivery takes more than six months [18, 21]. A lower absolute (mg/L plasma) and relative (% of total fatty acids) amount of DHA in maternal plasma phospholipids during pregnancy was seen in multigravids compared to primigravids , suggesting incomplete recovery of maternal DHA availability after delivery . Low concentrations of most n-3 fatty acids, including DHA, and high concentrations of AA are associated with lower birth weight and/or higher SGA risk [24, 25].
In the present study, we evaluated the potential role of the concentrations of DHA, AA, DGLA and EPA in the relationship between interpregnancy interval and adverse pregnancy outcome in a population-based cohort of 1,659 multiparous pregnant women.
Population and design
Data for this study were obtained from the Amsterdam Born Children and their Development (ABCD) study. This prospective, population-based cohort study examined the relationship between maternal lifestyle, ethnicity, psychosocial conditions and nutritional status during pregnancy and the child’s health at birth and in later life (http://www.abcd-study.nl). The study design has been described in detail elsewhere . In short, between January 2003 and March 2004, pregnant women living in Amsterdam were invited to enrol in the study during their first antenatal visit to their obstetric care provider. Detailed information about the mother's socio-demographic data, obstetric history, lifestyle, dietary habits and psychosocial factors was collected by the use of questionnaires, which were available in multiple languages. As part of a biomarker study, blood was drawn after the first prenatal visit to assess the level of fatty acids.
Study approval was obtained from the Central Committee on Research Involving Human Subjects in the Netherlands, the medical ethical committees of participating hospitals and the Registration Committee of Amsterdam. Written informed consent was obtained from all participants.
Primary outcome variables were birth weight (in grams) and SGA, which was defined as birth weight below the 10th percentile for gestational age based on sex- and parity -specific standards from the Dutch Perinatal Registry (available from the authors upon request). Gestational age at birth was determined by ultrasound (i.e. fetal biometry) or, if unavailable (< 10%), based on the first day of the last menstrual period.
Interpregnancy interval was computed as the amount of time between current and previous delivery dates, diminished by the duration of the current pregnancy. We divided interpregnancy interval into five categories; < 6, 6–11, 12–17, 18–23 and ≥ 24 completed months, and used 18–23 months as the reference category [1, 3].
Infant sex, birth weight and gestational age at birth (in weeks) were obtained from the Youth Health Department of the Public Health Service in Amsterdam. The date of the previous delivery was collected via questionnaire.
Fatty acid analysis in the ABCD study was previously described . In short, phospholipids isolated from plasma were saponified and the resulting fatty acids were methylated and measured by capillary gas chromatography with flame ionisation detection. The absolute amounts of arachidonic acid (20:4 n-6), docosahexaenoic acid (22:6 n-3) dihomo-gamma-linolenic acid (20:3 n-6) and eicosapentaenoic acid (20:5 n-3) (in mg/L plasma) were quantified on the basis of the recovery of an internal standard and expressed in a relative value (percentage of total amount of phospholipids-associated fatty acids).
A number of variables were considered and treated as potential confounders. Maternal age in years  (< 25, 25–34 or ≥ 35), parity  (1, 2 or ≥ 3), height  (in cm) and pre-pregnancy BMI  (in kg/m2) were obtained from the questionnaire. A random imputation procedure using linear regression analysis on the available variables was used to complete missing data on height (3.4% missing) and weight (9.5% missing) .
Maternal pregnancy-related variables were pregnancy intention (by inquiring whether participants did or did not want to become pregnant) , spontaneous pregnancy (by inquiring whether participants became pregnant with or without any medical intervention) , time to pregnancy (time needed to become pregnant; < 3, 3–12 or ≥ 12 months)  and start of prenatal care in weeks of gestation as calculated from the date of the first prenatal visit, the date of birth and gestational age at birth (<18, 18–23 or ≥24).
Lifestyle variables included self-reported smoking habits  and alcohol consumption [32, 33] (yes/no) before and/or during pregnancy and psychosocial stress (presence of 0, 1 or ≥ 2 stressors) . Stressors were measured by validated Dutch versions of internationally used questionnaires on depression , general anxiety , pregnancy-related anxiety , parenting stress  and work stress . Because there are no internationally accepted thresholds for non-normal scores in pregnant women, we set them at the 90th percentile.
Finally, the selected socio-demographic factors were cohabitant status (living with a partner or living alone) , years of education after primary school (< 6, 6–10 or ≥ 11 years)  and ethnicity. Ethnicity was determined by asking about the respondent’s country of birth and that of her mother (the Netherlands, Surinam, Turkey, Morocco or other) . All the variables were measured by questionnaire, unless mentioned otherwise.
We examined the relationship between maternal LCPUFA concentrations and pregnancy outcome by means of logistic regression (SGA) and linear regression (birth weight). Because we expected potential associations in the extreme values , we used quintiles to categorise the maternal plasma phospholipids concentration of each LCPUFA of interest. The middle category was used as a reference. To examine the relationship between IPI and maternal LCPUFA concentrations, we designated the quintile with the strongest association with adverse pregnancy outcome as the least favourable quintile. We then performed a logistic regression to evaluate whether IPI was associated with being in the least favourable LCPUFA quintile (versus any other LCPUFA quintile).
To evaluate the association between IPI and pregnancy outcome, we performed a logistic regression analysis (SGA) and a linear regression analysis (birth weight). Confounding factors were evaluated by performing multivariate, adjusted analyses in which each of the above-mentioned covariates was separately added to the model. In the SGA analyses, infant sex and gestational age were omitted from the multivariate analyses since they were already part of the definition of SGA. In the logistic regression analyses, a covariate was considered to be a confounder when the odds ratio of the univariate analyses deviated more than 10% after adding that specific covariate. In the linear regression analyses, we regarded a covariate to be a confounder when the deviation of the regression coefficient was greater than 10%. Using this confounder selection strategy, none of the aforementioned factors were identified as confounders, and therefore the final multivariate model only contained interpregnancy interval as an independent variable.
Finally, we assessed the potential influence of maternal LCPUFA concentrations on the relationship between interpregnancy interval and pregnancy outcome by repeating the adjusted logistic and linear regression analyses. In these analyses, LCPUFAs were treated as independent variables, first each LCPUFA separately and then all LCPUFAs simultaneously. Associations were considered statistically significant at p < 0.05. All analyses were conducted with the use of SPSS software (version 15.0; SPSS Inc., Chicago, IL).
Maternal and infant characteristics (n=1659)
Birth weight in g (mean ± SD)
3594 ± 505
Gestational age at birth in wk (mean ± SD)
40.0 ± 1,2
Interpregnancy interval (%)
< 6 mo
≥ 24 mo
< 25 y
≥ 35 y
Height in cm (mean ± SD)
168.5 ± 7.2
Prepregnancy BMI in kg/m 2 (mean ± SD)
23.4 ± 4.1
Unintended pregnancy (%)
Non-spontaneous pregnancy (%)
Time to pregnancy (%)
≥ 12 mo
Started prenatal care (%)
< 18 wk
≥ 24 wk
Alcohol consumption (%)
Yes, but not since pregnancy
Yes, also during pregnancy
Yes, but not since pregnancy
Yes, also during pregnancy
Psychosocial stressors (%)
Cohabitant status (% living alone)
≥ 11 y
Country of birth (%)
Other non-Western country
Other Western country
Country of birth of the mother’s mother (%)
Maternal essential fatty acids and pregnancy outcome
Concentration of the selected fatty acids by quintile in maternal plasma phospholipids at early pregnancy 1
Mean ± SD
Concentration total fatty acid (mg/L)
Concentration specific fatty acid 2
EPA (20:5 n-3)
0.63 ± 0.45
DHA (22:6 n-3)
4.07 ± 1.12
DGLA (20:3 n-6)
3.45 ± 0.75
AA (20:4 n-6)
9.48 ± 1.68
Results of the regression analyses relating essential fatty acid concentrations in quintiles and pregnancy outcome, defined as small for gestational age SGA and birth weight 1
Birth Weight (g)
Mean ± SD
Beta ± SE2
% of women with SGA birth within quintile
Odds ratio (95% CI)3
3595 ± 536
−182.5 ± 39.04
2.09 (1.32-3.30) 4
3579 ± 542
−66.1 ± 39.0
3645 ± 474
3664 ± 498
18.4 ± 38.9
3619 ± 489
−26.6 ± 39.0
3518 ± 520
−118.2 ± 39.24
3593 ± 539
−43.8 ± 39.2
3636 ± 505
3602 ± 471
−34.4 ± 39.2
3621 ± 484
−15.4 ± 39.2
3467 ± 472
−127.1 ± 38.94
3610 ± 520
16.5 ± 38.9
3594 ± 531
3634 ± 495
40.0 ± 38.9
3665 ± 486
71.0 ± 38.9
3606 ± 507
−52.8 ± 39.1
3617 ± 501
−42.2 ± 39.1
3659 ± 482
3574 ± 533
−85.0 ± 39.04
3514 ± 494
−145.0 ± 39.14
A statistically significant association between maternal AA concentrations and birth weight and SGA was also present. Women with AA concentrations in the highest quintile gave birth to infants with birth weights 145.0 g (SE: 39.1) lower and a nearly two times increased chance of SGA in comparison with women with AA concentrations in the middle quintile (OR = 1.88 (95% CI: 1.19–2.95).
Interpregnancy interval and maternal LCPUFA concentrations
Results of the logistic regression analysis of the association between interpregnancy interval and unfavorable maternal essential fatty acid status
Interpregnancy interval (mo)
% women in 1st Quintile
Mean ± SD concentration
Odds ratio2(95% CI)
% women in 1st Quintile
Mean ± SD concentration
Odds ratio2(95% CI)
% women in 1st Quintile
Mean ± (SD) concentration
Odds ratio2(95% CI)
% women in 5thQuintile
Mean (±SD) concentration
Odds ratio2(95% CI)
0.66 ± 0.47
4.77 ± 1.20
3.30 ± 0.69
9.34 ± 1.71
0.68 ± 0.44
4.70 ± 1.08
3.41 ± 0.75
9.28 ± 1.56
0.67 ± 0.38
4.85 ± 1.08
3.54 ± 0.74
9.28 ± 1.47
0.70 ± 0.53
4.75 ± 1.13
3.40 ± 0.70
9.35 ± 1.72
0.58 ± 0.45
4.57 ± 1.14
3.46 ± 0.77
9.66 ± 1.76
0.63 ± 0.45
4.67 ± 1.12
3.45 ± 0.75
9.48 ± 1.68
Interpregnancy interval and pregnancy outcome
Results of regression analyses of interpregnancy interval and pregnancy outcome (birth weight and SGA) adjusted for maternal LCPUFAs concentrations in early pregnancy 1
Interpregnancy interval (mo)
Small for Gestational Age (SGA)
Adjusted for LCPUFAs2
Adjusted for LCPUFAs2
Beta ± SE
Beta ± SE
Odds ratio (95%CI)
Odds ratio (95%CI)
3500 ± 489
−206.7 ± 73.13
−193.4 ± 72.13
3628 ± 478
−78.5 ± 45.3
−84.1 ± 44.8
3613 ± 483
−94.1 ± 45.14
−115.0 ± 44.6
3707 ± 499
3552 ± 519
−154.7 ± 38.03
−135.4 ± 37.83
Role of maternal essential fatty acid status in the relationship between interpregnancy interval and pregnancy outcome
After adjusting for each LCPUFA separately, the regression analyses on interpregnancy interval and birth weight/SGA did not show any important changes in regression coefficients or in odds ratios. When the four selected fatty acids were adjusted for simultaneously, there was no meaningful change in the observed relationships either (Table 5). Results were not materially different when LCPUFA variables were entered as quintiles instead of continuous variables (results not displayed).
This study examined the potential role of maternal LCPUFA status during early pregnancy in the association between short interpregnancy intervals with birth weight and SGA. Our results showed an association between IPIs of less than six months (and ≥ 24 months) and adverse pregnancy outcome (Table 5). These findings correspond to earlier observations within the ABCD cohort on the relationship between folate, interpregnancy interval and birth weight,  as well as with the findings of a meta-analysis of studies of the effects of short IPIs .
Our analyses of the relationship between maternal essential fatty acids and pregnancy outcome (Table 3) showed an increased risk of lower birth weight and/or SGA in women with low EPA, DHA and DGLA plasma phospholipids concentrations during early pregnancy. For AA, on the contrary, higher concentrations were associated with lower mean birth weights and increased risk of SGA. These results correspond with earlier observations in the ABCD cohort including nulliparas . A recent study of 782 women by Dirix et al.  described a relationship between increased birth weight and increased DHA concentrations measured in maternal plasma phospholipids in early pregnancy. The authors also reported that birth weight decreased as AA contents increased in late pregnancy. In contrast to our results, their findings on DGLA concentrations were in the same line as AA, with a negative association between maternal concentrations at delivery and birth weight.
Our analyses of interpregnancy interval and maternal LCPUFA concentrations did not reveal any meaningful associations between IPIs and individual LCPUFA concentrations (Table 4). In particular, no significant associations were observed for IPIs shorter that six months which have been shown (here and in other analyses) to be associated with adverse pregnancy outcomes. To our knowledge, the association between short IPI and LCPUFA status during a new pregnancy was not examined before. Findings from a study conducted by Al et al.  on maternal essential fatty acid and LCPUFA patterns during and after pregnancy imply a ‘recovery time’ of at least six months for the biochemical DHA status to normalise after pregnancy. Our results, however, indicated that fatty acid status as measured during pregnancy is not different for women with either short or intermediate interpregnancy intervals.
After adjusting for the selected maternal LCPUFA concentrations, we did not observe any meaningful changes in the relationship between interpregnancy interval and birth weight and/or risk of SGA (Table 5). The results of this study therefore do not support the hypothesis that maternal DGLA, AA, EPA or DHA concentrations during early pregnancy play an important role in the relationship between short IPI and adverse pregnancy outcome. This is likely due to the lack of association between short IPIs and maternal LCPUFA concentrations during early pregnancy.
Although 50% of the potential study population was excluded because of a lack of information on their fatty acid concentrations, a comparison of maternal and infant characteristics between included and excluded participants indicated that the resulting study population was representative for all. Because of a potential lack of power, we also decided not to investigate less common outcomes such as preterm birth (n = 64, 3.9%) or infant death. Since this study focused on birth weight and SGA, which are clinically relevant outcome measures, restricting the study to term-born infants made it possible to investigate birth weight as a reflection of health outcomes without the distorting effect of preterm delivery .
None of the preselected maternal and infant covariables acted as confounders in the association between IPI and birth weight/SGA. However, we cannot exclude the possibility of residual confounding due to unmeasured confounders or misclassification as a result of recall problems.
Measurement of essential fatty acid and LCPUFA concentrations in early pregnancy reflects the potential shortage due to a short interpregnancy interval. Moreover, this early stage of pregnancy is vitally import for fetal development [17, 44, 45] and is places a great demand on maternal nutrients. Although much is known about the essence and biological function of essential fatty acids in human life and pregnancy, we are still lacking basic information such as the range of ‘healthy’ concentrations of every fatty acid. Therefore, we chose to use the quintile found to be associated with the highest risk of adverse pregnancy outcome for the analysis of the influence of the selected LCPUFA concentration (quintile) on the relationship between IPI and birth weight and risk of SGA.
In conclusion, the study results do not support the idea that maternal early pregnancy DHA, AA, EPA or DGLA levels play an important role in the maternal depletion hypothesis. Although maternal supplementation may be beneficial for individual cases, based on the results of the current study we do not expect that routine periconceptional maternal fatty acid supplementation will mitigate the adverse effects of short IPIs on pregnancy outcomes.
- Conde-Agudelo A, Rosas-Bermudez A, Kafury-Goeta AC: Birth spacing and risk of adverse perinatal outcomes: a meta-analysis. JAMA. 2006, 295: 1809-1823. 10.1001/jama.295.15.1809.View ArticlePubMedGoogle Scholar
- Rodrigues T, Barros H: Short interpregnancy interval and risk of spontaneous preterm delivery. Eur J Obstet Gynecol RB. 2008, 136: 184-188. 10.1016/j.ejogrb.2007.03.014.View ArticleGoogle Scholar
- Zhu BP: Effect of interpregnancy interval on birth outcomes: findings from three recent US studies. Int J Gynaecol Obstet. 2005, 89 (Suppl 1): S25-S33.View ArticlePubMedGoogle Scholar
- Fedrick J, Adelstein P: Influence of pregnancy spacing on outcome of pregnancy. BMJ. 1973, 4: 753-756. 10.1136/bmj.4.5895.753.View ArticlePubMedPubMed CentralGoogle Scholar
- Smits L, Pedersen C, Mortensen P, van Os J: Association between short birth intervals and schizophrenia in the offspring. Schizophr Res. 2004, 70: 49-56. 10.1016/j.schres.2003.10.002.View ArticlePubMedGoogle Scholar
- Smits L, Zielhuis G, Jongbloet P, Bouchard G: The association of birth interval, maternal age and season of birth with the fertility of daughters: a retrospective cohort study based on family reconstitutions from nineteenth and early twentieth century Quebec. Paediatr Perinat Epidemiol. 1999, 13: 408-420. 10.1046/j.1365-3016.1999.00215.x.View ArticlePubMedGoogle Scholar
- Smits LJ, Willemsen WN, Zielhuis GA, Jongbloet PH: Conditions at conception and risk of menstrual disorders. Epidemiology. 1997, 8: 524-529. 10.1097/00001648-199709000-00009.View ArticlePubMedGoogle Scholar
- Winkvist A, Rasmussen KM, Habicht JP: A new definition of maternal depletion syndrome. Am J Public Health. 1992, 82: 691-694. 10.2105/AJPH.82.5.691.View ArticlePubMedPubMed CentralGoogle Scholar
- Miller JE: Birth intervals and perinatal health: an investigation of three hypotheses. Fam Plann Perspect. 1991, 23: 62-70. 10.2307/2135451.View ArticlePubMedGoogle Scholar
- Smits LJ, Jongbloet PH, Zielhuis GA: Preovulatory overripeness of the oocyte as a cause of ovarian dysfunction in the human female. Med Hypotheses. 1995, 45: 441-448. 10.1016/0306-9877(95)90218-X.View ArticlePubMedGoogle Scholar
- Smits LJ, Essed GG: Short interpregnancy intervals and unfavourable pregnancy outcome: role of folate depletion. Lancet. 2001, 358: 2074-2077. 10.1016/S0140-6736(01)07105-7.View ArticlePubMedGoogle Scholar
- King JC: The risk of maternal nutritional depletion and poor outcomes increases in early or closely spaced pregnancies. J Nutr. 2003, 133 (5 Suppl 2): 1732S-1736S.PubMedGoogle Scholar
- Van Eijsden M, Smits LJ, van der Wal MF, Bonsel GJ: Association between short interpregnancy intervals and term birth weight: the role of folate depletion. Am J Clin Nutr. 2008, 88: 147-153.PubMedGoogle Scholar
- Hornstra G: Essential fatty acids in mothers and their neonates. Am J Clin Nutr. 2000, 71 (5 Suppl): 1262S-1269S.PubMedGoogle Scholar
- Das UN: Essential fatty acids - a review. Curr Pharm Biotechnol. 2006, 7: 467-482. 10.2174/138920106779116856.View ArticlePubMedGoogle Scholar
- Calder PC, Krauss-Etschmann S, de Jong EC, Dupont C, Frick JS, Frokiaer H, et al: Early nutrition and immunity - progress and perspectives. Br J Nutr. 2006, 96: 774-790.View ArticlePubMedGoogle Scholar
- Innis SM: Fatty acids and early human development. Early Hum Dev. 2007, 83: 761-766. 10.1016/j.earlhumdev.2007.09.004.View ArticlePubMedGoogle Scholar
- Al MD, van Houwelingen AC, Kester AD, Hasaart TH, de Jong AE, Hornstra G: Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br J Nutr. 1995, 74: 55-68. 10.1079/BJN19950106.View ArticlePubMedGoogle Scholar
- Otto SJ, Houwelingen AC, Antal M, Manninen A, Godfrey K, Lopez-Jaramillo P, et al: Maternal and neonatal essential fatty acid status in phospholipids: an international comparative study. Eur J Clin Nutr. 1997, 51: 232-242. 10.1038/sj.ejcn.1600390.View ArticlePubMedGoogle Scholar
- Haggarty P: Effect of placental function on fatty acid requirements during pregnancy. Eur J Clin Nutr. 2004, 58: 1559-1570. 10.1038/sj.ejcn.1602016.View ArticlePubMedGoogle Scholar
- Otto SJ, van Houwelingen AC, Badart-Smook A, Hornstra G: Comparison of the peripartum and postpartum phospholipid polyunsaturated fatty acid profiles of lactating and nonlactating women. Am J Clin Nutr. 2001, 73: 1074-1079.PubMedGoogle Scholar
- Al MD, van Houwelingen AC, Hornstra G: Relation between birth order and the maternal and neonatal docosahexaenoic acid status. Eur J Clin Nutr. 1997, 51: 548-553. 10.1038/sj.ejcn.1600444.View ArticlePubMedGoogle Scholar
- Van den Ham EC, van Houwelingen AC, Hornstra G: Evaluation of the relation between n-3 and n-6 fatty acid status and parity in nonpregnant women from the Netherlands. Am J Clin Nutr. 2001, 73: 622-627.PubMedGoogle Scholar
- Van Eijsden M, Hornstra G, van der Wal MF, Vrijkotte TG, Bonsel GJ: Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth weight: a prospective cohort study. Am J Clin Nutr. 2008, 87: 887-895.PubMedGoogle Scholar
- Dirix CE, Kester AD, Hornstra G: Associations between neonatal birth dimensions and maternal essential and trans fatty acid contents during pregnancy and at delivery. Br J Nutr. 2009, 101: 399-407. 10.1017/S0007114508006740.View ArticlePubMedGoogle Scholar
- Newburn-Cook CV, Onyskiw JE: Is older maternal age a risk factor for preterm birth and fetal growth restriction? a systematic review. Health Care Women Int. 2005, 26: 852-875. 10.1080/07399330500230912.View ArticlePubMedGoogle Scholar
- Cogswell ME, Yip R: The influence of fetal and maternal factors on the distribution of birthweight. Semin Perinatol. 1995, 19: 222-240. 10.1016/S0146-0005(05)80028-X.View ArticlePubMedGoogle Scholar
- Mohllajee AP, Curtis KM, Morrow B, Marchbanks PA: Pregnancy intention and its relationship to birth and maternal outcomes. Obstet Gynecol. 2007, 109: 678-686. 10.1097/01.AOG.0000255666.78427.c5.View ArticlePubMedGoogle Scholar
- Helmerhorst FM, Perquin DA, Donker D, Keirse MJ: Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ. 2004, 328: 261-10.1136/bmj.37957.560278.EE.View ArticlePubMedPubMed CentralGoogle Scholar
- Basso O, Baird DD: Infertility and preterm delivery, birthweight, and caesarean section: a study within the Danish national birth cohort. Hum Reprod. 2003, 18: 2478-2484. 10.1093/humrep/deg444.View ArticlePubMedGoogle Scholar
- Crawford JT, Tolosa JE, Goldenberg RL: Smoking cessation in pregnancy: why, how, and what next. Clin Obstet Gynecol. 2008, 51: 419-435. 10.1097/GRF.0b013e31816fe9e9.View ArticlePubMedGoogle Scholar
- Livy DJ, Maier SE, West JR: Long-term alcohol exposure prior to conception results in lower fetal body weights. Birth Defects Res B Dev Reprod Toxicol. 2004, 71: 135-141. 10.1002/bdrb.20007.View ArticlePubMedGoogle Scholar
- Kuczkowski KM: The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol. 2007, 19: 578-585. 10.1097/GCO.0b013e3282f1bf17.View ArticlePubMedGoogle Scholar
- Hobel CJ, Goldstein A, Barrett ES: Psychosocial stress and pregnancy outcome. Clin Obstet Gynecol. 2008, 51: 333-348. 10.1097/GRF.0b013e31816f2709.View ArticlePubMedGoogle Scholar
- Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977, 1: 385-401. 10.1177/014662167700100306.View ArticleGoogle Scholar
- Spielberger CD: STAI manual for the state-trait anxiety inventory. 1970, Washington: Consulting Psychologists PressGoogle Scholar
- Huizink AC, Mulder EJ, Robles de Medina PG, Visser GH, Buitelaar JK: Is pregnancy anxiety a distinctive syndrome?. Early Hum Dev. 2004, 79: 81-91. 10.1016/j.earlhumdev.2004.04.014.View ArticlePubMedGoogle Scholar
- Crnic KA, Greenberg MT: Minor parenting stresses with young children. Child Dev. 1990, 61: 1628-1637. 10.2307/1130770.View ArticlePubMedGoogle Scholar
- Karasek R, Brisson C, Kawakami N, Houtman I, Bongers P, Amick B: The Job content questionnaire (JCQ): an instrument for internationally comparative assessments of psychosocial job characteristics. J Occup Health Psychol. 1998, 3: 322-355.View ArticlePubMedGoogle Scholar
- Luo ZC, Wilkins R, Kramer MS: Disparities in pregnancy outcomes according to marital and cohabitation status. Obstet Gynecol. 2004, 103: 1300-1307. 10.1097/01.AOG.0000128070.44805.1f.View ArticlePubMedGoogle Scholar
- Bibby E, Stewart A: The epidemiology of preterm birth. Neuro Endocrinol Lett. 2004, 25 (Suppl 1): 43-47.PubMedGoogle Scholar
- Troe EJ, Raat H, Jaddoe VW, Hofman A, Looman CW, Moll HA, et al: Explaining differences in birthweight between ethnic populations. The generation R study. BJOG. 2007, 114: 1557-1565. 10.1111/j.1471-0528.2007.01508.x.View ArticlePubMedGoogle Scholar
- Wilcox AJ: On the importance - and the unimportance - of birthweight. Int J Epidemiol. 2001, 30: 1233-1241. 10.1093/ije/30.6.1233.View ArticlePubMedGoogle Scholar
- Otto SJ, van Houwelingen AC, Badart-Smook A, Hornstra G: Changes in the maternal essential fatty acid profile during early pregnancy and the relation of the profile to diet. Am J Clin Nutr. 2001, 73: 302-307.PubMedGoogle Scholar
- Van Houwelingen AC, Puls J, Hornstra G: Essential fatty acid status during early human development. Early Hum Dev. 1992, 31: 97-111. 10.1016/0378-3782(92)90038-I.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://0-www.biomedcentral.com.brum.beds.ac.uk/1471-2393/13/23/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.